Drugs Causing Gynecomastia in Men of all Ages

In this blog, I will discuss the drugs causing gynecomastia and their mechanism of action, risk factors, diagnosis, and management. It is important to recognize drug-induced gynecomastia early to prevent progression and possible complications.

Gynecomastia, the enlargement of male breast tissue, is a common condition that affects a significant number of men worldwide. Although factors such as hormonal imbalances are the primary cause, research shows certain medications can cause gynecomastia.

Common drugs causing gynecomastia in men of all ages

The drugs that can cause gynecomastia include:

  • anti-androgen drugs
  • anabolic steroids
  • calcium channel blockers
  • proton pump inhibitors
  • anti-depressants
  • opioids
  • marijuana

Anti-androgen drugs, such as spironolactone and finasteride, block the effects of testosterone and promote breast tissue growth. Anabolic steroids, commonly used by bodybuilders, increase the production of estrogen and suppress testosterone levels, leading to gynecomastia.

Calcium channel blockers, a class of blood pressure medications, may also cause gynecomastia.

Drugs Causing Gynecomastia

Anti-androgen drugs

Anti-androgen drugs are medications that suppress or block the effects of androgens, the male sex hormones such as testosterone. Doctors use them to treat several medical conditions such as prostate cancer, hirsutism, and acne, as well as gender dysphoria in transgender individuals.

However, these drugs can cause gynecomastia by disrupting the normal balance of androgen and estrogen hormones in the body.

In males, testosterone plays a crucial role in the development of secondary sex characteristics, such as the growth of facial and body hair, deepening of the voice, and muscle mass. The body can also convert testosterone into estrogen, the female sex hormone, in small amounts in the body.

Anti-androgen drugs reduce the effects of testosterone, leading to an increase in estrogen levels, which can cause breast tissue growth. That is why they are among drugs causing gynecomastia.

The mechanism by which anti-androgen drugs cause gynecomastia is due to their ability to inhibit the androgen receptors in breast tissue. This results in a relative increase in estrogen receptor activation, leading to breast tissue growth.

Some of the commonly used anti-androgen drugs that can cause gynecomastia include spironolactone, flutamide, bicalutamide, and cyproterone acetate.

The severity of gynecomastia varies among individuals and depends on the type and dose of the anti-androgen drug used, as well as the duration of treatment.

Anabolic steroids

Anabolic steroids are synthetic versions of the hormone testosterone that many men use without prescription to enhance muscle mass, strength, and athletic performance. Doctors use them to treat certain medical conditions, such as delayed puberty and muscle-wasting diseases.

Anabolic steroids can cause gynecomastia by disrupting the normal balance of hormones in the body.

The enzyme aromatase, which is present in the body in small amounts, can convert testosterone into estrogen. Anabolic steroids increase the production of testosterone, which the body converts into estrogen. That leads to an imbalance between the two hormones.

This excess estrogen can stimulate breast tissue growth and cause gynecomastia.

The mechanism by which anabolic steroids cause gynecomastia is through the stimulation of the estrogen receptor in breast tissue. This leads to the proliferation of breast glandular tissue, resulting in breast enlargement.

The severity of gynecomastia depends on several factors such as the type and dose of anabolic steroids used, the duration of use, and individual susceptibility.

Gynecomastia caused by anabolic steroids can be reversible. However, in some cases, surgical intervention may be required to remove the excess breast tissue. Moreover, you have to chnage or stop using the drugs causing gynecomastia.

The use of anabolic steroids for non-medical purposes is illegal and can cause several other serious health problems. You can end up suffering from liver damage, cardiovascular disease, and psychiatric disorders.

Calcium channel blockers

Calcium channel blockers (CCBs) are a class of medications commonly used to treat hypertension (high blood pressure), angina (chest pain), and arrhythmias (abnormal heart rhythms). These drugs work by blocking calcium channels in the heart and blood vessels.

That leads to the relaxation of the blood vessels and a reduction in blood pressure. However, calcium channel blockers have also been associated with gynecomastia.

The exact mechanism by which calcium channel blockers cause gynecomastia is under research. However, researchers relate them to their effect on prolactin secretion.

Prolactin is a hormone produced by the pituitary gland that stimulates milk production in females. The hormone can cause breast tissue growth in males. Calcium channel blockers may increase prolactin secretion, leading to breast tissue growth and gynecomastia.

Other theories suggest that calcium channel blockers may cause gynecomastia by altering the balance of estrogen and androgen hormones in the body.

Some studies have also shown that CCBs may directly affect breast tissue growth by binding to estrogen receptors, which can lead to breast enlargement.

The risk of developing gynecomastia due to calcium channel blockers is relatively low. Moreover, may depend on the type and dose of medication used, as well as individual susceptibility.

Using CCBs for the treatment of hypertension and other medical conditions is more beneficial than the risks of developing gynecomastia. If gynecomastia occurs, ask your doctor to consider reducing the dose or switching to an alternative medication.

Proton pump inhibitors

Proton pump inhibitors (PPIs) are a class of medications used to treat gastro esophageal reflux disease (GERD), peptic ulcer disease, and other acid-related disorders. PPIs work by reducing the production of stomach acid by blocking the enzyme responsible for acid secretion in the stomach.

Although PPIs are generally safe and effective, they have been associated with gynecomastia in some cases.

The mechanism by which PPIs cause gynecomastia is not clear, but researchers think relate it to their effect on the metabolism of hormones in the liver. PPIs inhibit the activity of CYP2C19, a liver enzyme responsible for the metabolism of estrogen and other hormones.

This can lead to an accumulation of estrogen in the body, which can cause breast tissue growth and gynecomastia.

Other theories suggest that PPIs may cause gynecomastia by altering the balance of estrogen and androgen hormones in the body. Some studies have also shown that PPIs may interfere with the binding of androgen hormones to their receptors.

That can lead to an increase in estrogen activity and breast tissue growth.

The risk of developing gynecomastia due to PPIs is relatively low. In addition, it may depend on the type and dose of medication used, as well as individual susceptibility.

PPIs treat acid-related disorders, and their benefits outweigh the risks of developing gynecomastia. If gynecomastia occurs, you can opt to reduce the dose or switch to an alternative medication. Ask your doctor to advise you about it.

Anti-depressants

Antidepressants are a class of medications used to treat depression, anxiety, and other mood disorders. There are several types of antidepressants, including selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs).

Antidepressants are generally safe and effective if you follow the doctor’s prescription. However, they have been associated with gynecomastia in some cases.

Like other drugs causing gynecomastia, the mechanism by which antidepressants cause gynecomastia is not clear yet. However, researchers think they can alter hormone levels in the body.

Antidepressants can interfere with the production and metabolism of hormones, including testosterone and estrogen.

This can lead to an imbalance between the two hormones, with an excess of estrogen causing breast tissue growth and gynecomastia.

SSRIs, which are the most commonly prescribed type of antidepressant, increase prolactin secretion in some people. Prolactin is a hormone produced by the pituitary gland that can stimulate breast tissue growth in males.

Elevated levels of prolactin may be responsible for the development of gynecomastia in some people taking SSRIs.

Other theories suggest that antidepressants may cause gynecomastia by interfering with the function of androgen receptors. That can lead to a reduction in testosterone activity and an increase in estrogen activity.

Overall, the risk of developing gynecomastia due to antidepressants is relatively low. Furthermore, it depends on the type and dose of medication used, as well as individual susceptibility.

The benefits of using antidepressants for the treatment of mood disorders outweigh the risks of developing gynecomastia. If you get gynecomastia for using SSRIs, request for a change of dosage or alternatives.

Opioids

Opioids are a class of medications used to relieve pain. They work by binding to specific receptors in the brain and spinal cord, which reduces the perception of pain. Opioids include prescription drugs such as oxycodone, hydrocodone, and codeine, as well as illegal drugs such as heroin.

While opioids are generally safe and effective for short-term use, they have been associated with gynecomastia in some cases. And like other drugs causing gynecomastia, their exact causative mechanism is not clear.

However, researchers relate their action to their effect on hormone levels in the body. Opioids can interfere with the production and metabolism of hormones, including testosterone and estrogen.

This can lead to an imbalance between the two hormones, with an excess of estrogen causing breast tissue growth and gynecomastia.

Opioids can also increase prolactin secretion in some people. Prolactin is a hormone produced by the pituitary gland that can stimulate breast tissue growth in males.

Other theories suggest that opioids may cause gynecomastia by interfering with the function of androgen receptors. That can lead to a reduction in testosterone activity and an increase in estrogen activity.

The risk of developing gynecomastia due to opioids is relatively low and may depend on the type and dose of medication used, as well as individual susceptibility.

For many patients, the benefits of using opioids for pain management usually outweigh the risks of developing gynecomastia. Moreover, if gynecomastia occurs, lowering the dose or getting an opiod alternative can stop its progression..

Marijuana

Marijuana, also known as cannabis, is a psychoactive drug extracted from the Cannabis sativa plant. It is typically smoked, vaporized, or ingested in food or drink. Many people use marijuana for its medicinal properties.

However, some users have reported development of gynecomastia after continuous use.

The mechanism by which marijuana causes gynecomastia is not clear. However, researchers believe it can have an effect on hormone levels in the body. Marijuana contains compounds called cannabinoids.

These can interfere with the production and metabolism of hormones, including testosterone and estrogen. This can lead to an imbalance between the two hormones, with an excess of estrogen causing breast tissue growth and gynecomastia.

Marijuana can also increase prolactin secretion in some people. Prolactin is a hormone produced by the pituitary gland that can stimulate breast tissue growth in males. Elevated levels of prolactin may be responsible for the development of gynecomastia in some people using marijuana.

Other theories suggest that marijuana may cause gynecomastia by interfering with the function of androgen receptors. That can lead to a reduction in testosterone activity and an increase in estrogen activity.

The risk of developing gynecomastia due to marijuana use is relatively low and may depend on the frequency and duration of use, as well as individual susceptibility. If gynecomastia occurs after marijuana use, reducing or discontinuing marijuana use may be considered.

Risk factors for developing gynecomastia due to drug use

Several factors can increase the risk of developing gynecomastia due to drug use. These factors include age, drug dose, duration of drug use, genetics, body mass index (BMI), and coexisting medical conditions.

Age

Age is a significant risk factor for gynecomastia, as breast tissue growth is more common in adolescent boys and older men. During puberty, hormonal changes can lead to temporary breast enlargement, which usually resolves within two years.

In older men, a decline in testosterone production can cause an imbalance between estrogen and testosterone, leading to breast tissue growth.

Dose and duration of drug use

The dose and duration of drug use can also affect the risk of developing gynecomastia. Higher doses and longer durations of use of drugs that cause gynecomastia are associated with a greater risk of breast tissue growth.

Genetics

Genetics can also play a role in the development of gynecomastia. Some individuals may be more susceptible to the effects of certain drugs due to genetic variations in hormone metabolism or receptor function.

Additionally, some inherited conditions, such as Klinefelter syndrome, can increase the risk of gynecomastia. That is why not all men are affected by drugs causing gynecomastia.

Body mass index

Body mass index (BMI) is another risk factor for gynecomastia. Obesity can increase the risk of breast tissue growth by increasing estrogen levels in the body.

Additionally, higher levels of body fat can convert testosterone to estrogen, further contributing to the imbalance between the two hormones.

Coexisting medical conditions

Coexisting medical conditions, such as liver or kidney disease, can also increase the risk of gynecomastia. These conditions can impair the metabolism and excretion of hormones, leading to an imbalance between estrogen and testosterone.

Certain medications used to treat these conditions may also cause gynecomastia as a side effect.

What to do about gynecomastia risk factors

One or a combination of these risk factors can increase the likelihood of developing gynecomastia due to drug use. If you have any concerns about breast tissue growth, consult your healthcare provider. They can evaluate the potential causes and recommend appropriate treatment options.

Diagnosis and management of drug-induced gynecomastia

The diagnosis and management of drug-induced gynecomastia involve a thorough evaluation of medical history and physical examination, laboratory tests and imaging studies, treatment options, and prevention strategies.

Evaluation of medical history and physical examination

Evaluation of medical history and physical examination are crucial in identifying potential causes of gynecomastia, including drug use. Healthcare providers will inquire about any medications or supplements that the patient is taking and review their medical history.

They then use that data to identify any underlying conditions that may be contributing to breast tissue growth. They may also conduct a physical examination to assess the extent and nature of breast tissue enlargement.

Laboratory tests and imaging studies

A doctor can also order laboratory tests and imaging studies, such as hormone level testing and breast ultrasound. These can confirm the diagnosis of drug-induced gynecomastia and rule out other underlying causes, such as tumors or infections.

Treatment options

The management of drug-induced gynecomastia involves several treatment options. The right option depends on the severity and duration of breast tissue growth.

Discontinuing or switching to an alternative medication that does not cause gynecomastia is often the first step in treating drug-induced gynecomastia.

In cases where you cannot stop medication, adding another medication, such as tamoxifen or raloxifene, can help reduce breast tissue growth. In severe cases, surgery may be necessary to remove the excess breast tissue.

Prevention of gynecomastia due to drug use

Preventing gynecomastia due to drug use involves awareness of the potential risk factors, and communication with healthcare providers.

You can inform your healthcare provides about any medications or supplements you are taking. Moreover, report any symptoms of breast tissue growth promptly.

Healthcare providers should also monitor patients on medications that may cause gynecomastia and adjust treatment as necessary.

Drugs causing man boobs

Drugs causing gynecomastia include anti-androgens, anabolic steroids, calcium channel blockers, proton pump inhibitors, antidepressants, and opioids, among others. It is important you recognize drug-induced gynecomastia early to prevent potential physical and psychological harm to patients.

Healthcare professionals play a vital role in preventing and managing drug-induced gynecomastia. They can educate you on potential risk factors, monitoring patients on medications that may cause gynecomastia, and promptly addressing any symptoms of breast tissue growth.

Early identification and management of drug-induced gynecomastia can lead to better treatment outcomes and improved quality of life for patients.

Author

  • Dr. Wells, M.D.

    Dr. Barbara Wells is a researcher and medical doctor. She works at Baylor College of Medicine and has published several research articles on topics related to obesity and weight loss. Her research focuses on pharmacotherapy, medication, and supplements to treat obesity and related conditions.

Leave a Comment